| Weight | 1 kg |
|---|---|
| Dimensions | 10 × 10 × 10 cm |
| Pack Size | 100ul, 50ul |
| Immunogen Species | Human |
| Host | |
| Species Reactivity | Human |
| Tested Applications | ELISA, WB, IF, IP; Recommended dilution: WB:1:500-1:5000, IF:1:20-1:200, IP:1:200-1:1000 |
| Storage | -20?C or -80?C |
| BRAND | BIOTUVA, ELAB SCIENCE |
$315.00 – $525.00
Aliases
Ribosomal protein S6 kinase alpha-1, S6K-alpha-1, 90 kDa ribosomal protein S6 kinase 1, p90-RSK 1, p90RSK1, p90S6K, MAP kinase-activated protein kinase 1a, MAPK-activated protein kinase 1a, MAPKAP kinase 1a, MAPKAPK-1a, Ribosomal S6 kinase 1, RSK-1, RPS6KA1, MAPKAPK1A, RSK1
UniprotID
Q15418
Immunogen
A synthesized peptide derived from human Phospho-RPS6KA1 (T359+S363)
SKU: BTV-RA618984A359phHU
Categories: Antibody, Recombinant Antibodies
Be the first to review “Phospho-RPS6KA1 (T359+S363) Antibody” Cancel reply

Western Blot Positive WB detected in?HepG2 whole cell lysate(treated with EGF or not) All lanes?Phospho-RPS6KA1 antibody at 0.69?g/ml Secondary Goat polyclonal to rabbit IgG at 1/50000 dilution Predicted band size: 90 KDa Observed band size: 90 KDa
Related products
Antibody
$150.00 – $250.00
This product has multiple variants. The options may be chosen on the product page
Antibody
$150.00 – $250.00
This product has multiple variants. The options may be chosen on the product page
Antibody
$150.00 – $250.00
This product has multiple variants. The options may be chosen on the product page
Antibody
$150.00 – $250.00
This product has multiple variants. The options may be chosen on the product page
Antibody
$150.00 – $250.00
This product has multiple variants. The options may be chosen on the product page
Antibody
$150.00 – $250.00
This product has multiple variants. The options may be chosen on the product page
Antibody
$150.00 – $250.00
This product has multiple variants. The options may be chosen on the product page
Antibody
$150.00 – $250.00
This product has multiple variants. The options may be chosen on the product page




Reviews
There are no reviews yet.